Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Combining oncolytic HSV-1 with immunogenic cell death-inducing drug mitoxantrone breaks cancer immune tolerance and improves therapeutic efficacy.

Workenhe ST, Pol JG, Lichty BD, Cummings DT, Mossman KL.

Cancer Immunol Res. 2013 Nov;1(5):309-19. doi: 10.1158/2326-6066.CIR-13-0059-T. Epub 2013 Aug 19.

3.

Yeast recombinase FLP functions effectively in human cells for construction of adenovirus vectors.

Ng P, Cummings DT, Evelegh CM, Graham FL.

Biotechniques. 2000 Sep;29(3):524-6, 528.

4.

An enhanced system for construction of adenoviral vectors by the two-plasmid rescue method.

Ng P, Parks RJ, Cummings DT, Evelegh CM, Graham FL.

Hum Gene Ther. 2000 Mar 20;11(5):693-9.

PMID:
10757349
5.

A high-efficiency Cre/loxP-based system for construction of adenoviral vectors.

Ng P, Parks RJ, Cummings DT, Evelegh CM, Sankar U, Graham FL.

Hum Gene Ther. 1999 Nov 1;10(16):2667-72.

PMID:
10566894

Supplemental Content

Loading ...
Support Center